The Group’s Revenue Hits New HeightsNet profit for 1H2023 increased more than 2.8 times YoYBenefited from the Full Resumption of Normal TravelRevenue Continues to Generate Profit in Future Results Highlights Since the full resumption of normal travel between Hong Kong, Macau and Mainland China, the number of travellers has rebounded significantly, which is favourable for the … Read more
Ongoing cost optimization to achieve profitability in 2023 Q1 2023 gross margin (non IFRS)1 up 1300 basis points year over year Quarterly conference call scheduled for May 30, 2023 at 5 pm ET TORONTO, May 30, 2023 /PRNewswire/ – Newtopia Inc. (“Newtopia” or the “Company“) (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health platform creating … Read more
COPENHAGEN, Denmark, May 25, 2023 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) hereby publishes the interim report Q1 2023. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report. Curasight’s CEO Ulrich Krasilnikoff comments: “During the first quarter … Read more
MUMBAI, India, May 24, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31st March 2023. Consolidated Financial Highlights (In INR Crores) Particulars Quarterly Full Year Q4 FY23 Q4 FY22 YoYGrowth Q3 FY23 QoQGrowth FY23 FY22 YoYGrowth Revenue from … Read more
As of March 31, 2023, the Company had $11.5 million in cash, cash equivalents, and short-term bank deposits RA’ANANA, Israel, May 18, 2023 /PRNewswire/ — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, announced today its financial results for the first quarter ended March … Read more
First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million and cash on balance sheet of $115.8 million NEW YORK, May 17, 2023 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer … Read more
BEIJING, May 17, 2023 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman Islands incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the three months ended March 31, 2023. Wei-Wu He, Ph.D., CASI’s Chairman and Chief Executive Officer, commented, “Revenue for EVOMELA® was $8.3 million … Read more
STOCKHOLM, May 17, 2023 /PRNewswire/ — FIRST QUARTER (JANUARY – MARCH 2023) Order intake SEK 206.6 M (272.5) Net sales SEK 230.2 M (208.1) Operating profit SEK 23.7 M (29.6) Profit after tax SEK 17.6 M (19.3) Earnings per share before/after dilution SEK 0.51 (0.56) Cash flow SEK 84.5 M (35.3) Order backlog SEK 1,903.3 … Read more